Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0425
+0.0073 (20.81%)
At close: Oct 16, 2025
Carisma Therapeutics Revenue
Carisma Therapeutics had revenue of $10.77M in the twelve months ending June 30, 2025, down -48.01% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.
Revenue (ttm)
10.77M
Revenue Growth
-48.01%
P/S Ratio
0.17
Revenue / Employee
234.07K
Employees
46
Market Cap
1.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.63M | 4.71M | 31.59% |
Dec 31, 2023 | 14.92M | 5.09M | 51.71% |
Dec 31, 2022 | 9.83M | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
American Oncology Network | 1.76B |
Jushi Holdings | 256.36M |
AMJ Global Technology | 39.00 |
Carisma Therapeutics News
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, CARM, ENZB on Behalf of Shareholders - GlobeNewsWire
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders - PRNewsWire
- 4 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE and CARM on Behalf of Shareholders - PRNewsWire
- 4 months ago - CARM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Carisma Therapeutics Inc. Is Fair to Shareholders - Business Wire
- 7 months ago - Carisma Therapeutics Provides Corporate Updates - PRNewsWire
- 8 months ago - Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - PRNewsWire
- 9 months ago - Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 11 months ago - Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline - PRNewsWire